Anticp4: Anticancer Peptide Prediction

AntiCP 4.0 is the latest upgraded version in the AntiCP series, specifically developed for the prediction, analysis, and design of anticancer peptides (ACPs). This version utilizes an extensively curated peptide dataset, allowing for highly reliable identification and optimization of peptides with anticancer potential. AntiCP 4.0 expands the capabilities of previous versions by offering improved performance, enhanced design tools, and a user-friendly interface tailored to support peptide-based therapeutic research. It provides an integrated platform where users can predict, design, and refine peptide candidates in a single environment.